BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2009
View Archived Issues
Imatinib prevents, reverses diabetes in nonobese mice
Read More
Lower doses of PfCP2.9 malaria vaccine candidate tested in phase I study
Read More
Device captures metastatic cells from circulation and delivers apoptotic signal
Read More
MenACWY-TT meningococcal vaccine immunogenic in adolescents
Read More
FDA approves Prism's NDA for Nexterone in ventricular fibrillation and tachycardia
Read More
Clinical Data presents results from Vilazodone and Stedivaze trials
Read More
Fasgen and Centocor sign research and license agreement in oncology
Read More
Synta and Roche enter agreement for small-molecule drugs targeting CRACM channels
Read More
Novel anti-EGFR family member antibodies described in recent patent
Read More
Xenon discloses new sodium channel blockers with analgesic properties
Read More
Astellas claims new N-type calcium channel blockers for alleviating pain
Read More
Novartis imparts novel chemokine CXCR2 receptor antagonists in recent patent
Read More
Recent Argenta Discovery patent discloses new HNE inhibitors for respiratory disorders
Read More
Quark doses first patient in phase I/II QPI-1002 trial for delayed graft function
Read More
Aegera initiates phase II AEG-35156 trial in non-small cell lung cancer
Read More
Michael J. Fox Foundation awards grant to Arcadia for development of ERbeta agonists in PD
Read More
FDA grants approval to Ark to initiate patient recruitment into phase III trial of Trinam
Read More
BioMimetic completes enrollment into clinical trial of Augment Bone Graft
Read More
Sinclair and Graceway sign U.S. agreement for Atopiclair for atopic dermatitis
Read More
FDA extends PDUFA action date for Ipsen's Reloxin BLA for glabellar lines
Read More
PAION's sedative CNS-7056 meets target profile in proof-of-concept study
Read More
Juvaris presents positive data from JVRS-100 adjuvanted flu vaccine trial
Read More
RegeneRx reports phase II RGN-137 results in chronic pressure ulcers
Read More
SCY-635 demonstrates proof-of-concept in HCV-infected adults
Read More
Sucampo completes enrollment in cobiprostone trial for NSAID-induced ulcers
Read More